OPHTHALMOLOGICAL COMPOSITIONS Russian patent published in 2021 - IPC A61K47/14 A61K47/44 A61K45/08 A61P27/02 

Abstract RU 2756758 C2

FIELD: medicine; ophthalmology.

SUBSTANCE: group of inventions relates to the field of medicine, namely to ophthalmology; it is intended for the treatment and/or prevention of eye diseases. A sterile ophthalmological composition in the form of nano-emulsion contains an oil phase containing castor oil and medium-chain triglyceride; one or several surfactants; and an aqueous phase. A pH value of the specified composition is 5.0-9.0. Castor oil and medium-chain triglyceride are in a mass ratio from 50:1 to 1:50. The composition does not contain cyclosporine A. The use of the specified composition for the production of a drug for the treatment and/or prevention of eye diseases is also provided. Besides, a method for the prevention and/or treatment of eye diseases is presented, including injection to a patient of the effective amount of the specified composition. Eye diseases are: dry eyes, conjunctivitis, dermatitis, blepharitis, entropion, dangling eyelid syndrome, ophthalmopathy caused by thyroid disease, pterygium, conjunctivochalyasis, damage to the epithelium or anterior chamber, lack of limbal cells, corneal ulcers, keratitis, episcleritis and uveitis.

EFFECT: use of the group of inventions allows increasing the efficiency of the treatment of the specified eye diseases.

14 cl, 9 dwg, 3 tbl, 3 ex

Similar patents RU2756758C2

Title Year Author Number
OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE 2015
  • Um, Key-An
  • Kim, Yeong-Mok
  • Hwang, Deok-Kyu
  • Ahn, Mi Sun
  • Nam, Seung Kwan
  • Ko, Dae Woong
  • Hong, Sung-Woon
  • Lim, Jong Hwan
RU2700927C2
PREVENTIVE OR THERAPEUTIC AGENT FOR TREATMENT OF KERATOCONJUCTIVAL DISORDERS 2006
  • Esida Atsusi
  • Khirai Sinitiro
  • Nakamura Masatsugu
RU2406499C2
COMPOSITION, METHOD FOR TRANSDERMAL DELIVERY OF POLYAFRON, METHOD FOR CONTROLLED RELEASE OF INGREDIENT 2016
  • Schmitt, Mathieu
  • Kido, Kazutaka
  • Inagaki, Koji
  • Bouttaz, Adeline
RU2758335C2
THERAPEUTIC MEDICATION AGAINST CORNEAL-CONJUNCTIVAL DISTURBANCE 2006
  • Sibagaki Keiiti
  • Khirai Sin-Itiro
  • Nakamura Masatsugu
RU2423127C2
COMPOSITION OF PROLONGED ACTION OF CYCLOSPORIN OF FORM 2 2012
  • Blanda Vendi M.
  • Ettar Mejssa
RU2639393C2
CLOBETAZOLE COMPOSITION IN THE FORM OF OIL-IN-WATER NANO-EMULSION 2018
  • Sanagustin Aquilue, Javier
  • Lendinez Gris, Maria Del Carmen
  • Delgado Ganan, Maria Isabel
RU2759901C2
CYCLOSPORINE SUSPENSIONS A OF FORM 2 2012
  • Gor Anuradkha V.
  • Mokhanti Prem Svarup
  • Farnes E. Kvinn
RU2641963C2
THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS 2013
  • Kimura Kazukhiro
RU2659203C2
OIL-IN-WATER OPHTHALMIC EMULSIONS CONTAINING PROSTAGLANDINS 2008
  • Karli Fabio
  • Baronian Miran
  • Shmid Rene
  • Chillini Ehlizabet
RU2460516C2
MEDICINAL FORMS FOR EXTERNAL USE CONTAINING CYCLOSPORINE AND USE THEREOF 2017
  • Weiss, Sidney L.
  • Mitra, Ashim K.
  • Mcnally, Eugene J.
RU2747455C2

RU 2 756 758 C2

Authors

Delgado Ganan, Isabel

Marchan Sancho, Sandra

Iskierdo Torres, Fransiska

Dates

2021-10-05Published

2017-07-06Filed